- Q1 2024 Cellectis SA Earnings Call TranscriptMay 29, 2024€2.52 (-1.56%)Earnings
- Q3 2023 Cellectis SA Earnings Call TranscriptNov 07, 2023€2.08 (-17.46%)Earnings
- Cellectis SA at Jefferies Cell & Genetic Medicine Summit TranscriptSep 26, 2023
- Q2 2023 Cellectis SA Earnings Call TranscriptAug 04, 2023€1.71 (+1.79%)Earnings
- Cellectis SA at Goldman Sachs Healthcare Conference TranscriptJun 15, 2023
- Q1 2023 Cellectis SA Earnings Call TranscriptMay 05, 2023€1.63 (+1.24%)Earnings
- Cellectis SA at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Cellectis SA Earnings Call TranscriptMar 09, 2023€1.95Earnings
- Cellectis SA Corporate Analyst Meeting (Virtual) TranscriptDec 13, 2022
- Q3 2022 Cellectis SA Earnings Call TranscriptNov 04, 2022€2.38 (-3.25%)Earnings
- Atara Biotherapeutics Inc, Cellectis SA and 2Seventy Bio Inc at Citi BioPharma Conference- Panel TranscriptSep 07, 2022
- Q2 2022 Cellectis SA Earnings Call TranscriptAug 05, 2022€2.92 (-5.81%)Earnings
- Cellectis SA at Goldman Sachs Global Healthcare Conference TranscriptJun 16, 2022
- Cellectis SA at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Q1 2022 Cellectis SA Earnings Call TranscriptMay 13, 2022€2.84 (+9.23%)Earnings
- Cellectis SA at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Q4 2021 Cellectis SA Earnings Call TranscriptMar 04, 2022€3.32 (-6.74%)Earnings
- Cellectis SA at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- Q3 2021 Cellectis SA Earnings Call TranscriptNov 05, 2021€10.5 (-1.87%)Earnings
- Cellectis SA at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Cellectis SA Earnings Call TranscriptAug 06, 2021€11.3 (+3.67%)Earnings
- Cellectis SA at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Q4 2020 Cellectis SA Earnings Call TranscriptMar 05, 2021€15.8 (-3.07%)Earnings
- Cellectis SA at Barclays Virtual Gene Editing & Gene Therapy Summit - Presentation TranscriptNov 16, 2020
- Q3 2020 Cellectis SA Earnings Call TranscriptNov 06, 2020€15.1 (+8.63%)Earnings
- Cellectis SA at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Q2 2020 Cellectis SA Earnings Call TranscriptAug 06, 2020€14.8 (+2.78%)Earnings
- Cellectis SA Chardan Leadership Call TranscriptMay 27, 2020
- Q1 2020 Cellectis SA Earnings Call TranscriptMay 07, 2020€12.8 (-1.54%)Earnings
- Q4 2019 Cellectis SA Earnings Call TranscriptMar 05, 2020€14Earnings
- Q3 2019 Cellectis SA Earnings Call TranscriptNov 07, 2019€11.3 (+2.73%)Earnings
- Cellectis SA at Citi Biotech Conference TranscriptSep 04, 2019
- Cellectis SA at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2019
- Cellectis SA at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Q4 2018 Cellectis SA Earnings Call TranscriptMar 12, 2019€16.1 (+1.26%)Earnings
Cellectis SA at Barclays Gene Editing & Gene Therapy Summit (Virtual) Transcript
Thank you, everyone, for attending Barclays' first Gene Editing & Gene Therapy Summit. My name is Gena Wang. I'm SMID cap biotech analyst at Barclays. Before I start, I wanted to thank our health care corporate access team and event team to make this event possible. I also want to thank my wonderful team members, Sheldon Fan, [Tong Liu] and [Hashida Apolocheti] who burned the midnight oil to make this summit happen.
Gene therapy and gene editing are still -- is the emerging field among all the therapeutics. And we have seen -- overseeing evolving dynamics from initial skepticism to enthusiasm and now more mature process from the regulator following the initial learning phase.
We will discuss some of the topics in our panel discussion today. In 2021, we saw some progress regarding clinical data and a regulatory update. We finalized our clinical hold removal for spinal muscular atrophy of Zolgensma intrathecal program. We also saw initial impressive data from in vivo genetic approach. We continue to believe
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)